BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24351623)

  • 21. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
    King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
    J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-interferon-γ Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes.
    Hidekawa C; Yoshimi R; Kishimoto D; Kato H; Mitsuhashi M; Sakurai N; Sato Y; Uehara T; Iizuka Y; Komiya T; Hamada N; Nagai H; Soejima Y; Kamiyama R; Takase-Minegishi K; Kirino Y; Sakagami T; Nakajima H
    Intern Med; 2022 Aug; 61(15):2377-2385. PubMed ID: 35022342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
    Furuya H; Ikeda K; Miyachi K; Nakamura K; Suzuki K; Furuta S; Tamachi T; Hirose K; Sakagami T; Nakajima H
    Rheumatology (Oxford); 2017 Jul; 56(7):1241-1243. PubMed ID: 28371927
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary Mycobacterium fortuitum infection with cervical lymphadenitis in a patient carrying autoantibodies to interferon-γ.
    Suzuki K; Terada J; Sasaki Y; Kawasaki T; Naito Y; Sakurai T; Tanabe N; Tatsumi K
    Intern Med; 2014; 53(12):1361-4. PubMed ID: 24930658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-interferon-γ autoantibody-associated disseminated Mycobacterium abscessus infection mimicking parotid cancer with multiple metastases: A case report.
    Chang PH; Chuang YC
    Medicine (Baltimore); 2017 Sep; 96(39):e8118. PubMed ID: 28953638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.
    Hong GH; Ortega-Villa AM; Hunsberger S; Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Rosen LB; Zerbe CS; Holland SM
    Clin Infect Dis; 2020 Jun; 71(1):53-62. PubMed ID: 31429907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet's syndrome and beyond.
    Chan JF; Trendell-Smith NJ; Chan JC; Hung IF; Tang BS; Cheng VC; Yeung CK; Yuen KY
    Dermatology; 2013; 226(2):157-66. PubMed ID: 23652167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.
    Patel SY; Ding L; Brown MR; Lantz L; Gay T; Cohen S; Martyak LA; Kubak B; Holland SM
    J Immunol; 2005 Oct; 175(7):4769-76. PubMed ID: 16177125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.
    Döffinger R; Helbert MR; Barcenas-Morales G; Yang K; Dupuis S; Ceron-Gutierrez L; Espitia-Pinzon C; Barnes N; Bothamley G; Casanova JL; Longhurst HJ; Kumararatne DS
    Clin Infect Dis; 2004 Jan; 38(1):e10-4. PubMed ID: 14679469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sweet Syndrome precipitated by
    Thapa P; Mohr K; Campbell KK; Saccente M
    J Investig Med High Impact Case Rep; 2021; 9():2324709621990771. PubMed ID: 33533284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
    Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA.
    Nithichanon A; Chetchotisakd P; Matsumura T; Takahashi Y; Ato M; Sakagami T; Lertmemongkolchai G
    Sci Rep; 2020 Jun; 10(1):8968. PubMed ID: 32488051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ.
    Ishii T; Tamura A; Matsui H; Nagai H; Akagawa S; Hebisawa A; Ohta K
    J Infect Chemother; 2013 Dec; 19(6):1152-7. PubMed ID: 23456204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult-onset immunodeficiency in Thailand and Taiwan.
    Browne SK; Burbelo PD; Chetchotisakd P; Suputtamongkol Y; Kiertiburanakul S; Shaw PA; Kirk JL; Jutivorakool K; Zaman R; Ding L; Hsu AP; Patel SY; Olivier KN; Lulitanond V; Mootsikapun P; Anunnatsiri S; Angkasekwinai N; Sathapatayavongs B; Hsueh PR; Shieh CC; Brown MR; Thongnoppakhun W; Claypool R; Sampaio EP; Thepthai C; Waywa D; Dacombe C; Reizes Y; Zelazny AM; Saleeb P; Rosen LB; Mo A; Iadarola M; Holland SM
    N Engl J Med; 2012 Aug; 367(8):725-34. PubMed ID: 22913682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.
    Holland SM; Eisenstein EM; Kuhns DB; Turner ML; Fleisher TA; Strober W; Gallin JI
    N Engl J Med; 1994 May; 330(19):1348-55. PubMed ID: 7908719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.
    Chetchotisakd P; Anunnatsiri S
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1125-31. PubMed ID: 25417515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
    Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
    Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
    Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
    Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case of Disseminated Non-tuberculous Mycobacteriosis with a Skull Lesion Controlled by Resection after Exacerbation during Antimicrobial Chemotherapy in a Patient Positive for Anti-IFN-γ-neutralizing Autoantibodies.
    Chubachi K; Taima K; Ishidoya M; Tanaka Y; Kurose A; Tasaka S
    Intern Med; 2023 Dec; ():. PubMed ID: 38044155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.